Inhibition of paracrine angiotensin-converting enzyme in vivo: Effects on interstitial glucose and lactate concentrations in human skeletal muscle

European Journal of Clinical Investigation

Volumn 27, Issue 10, 1997, Pages 825-830

  Muller M ^a,b   Fasching, P ^a   Schmid, R ^a   Burgdorff, T ^a   Waldhausl W ^a   Eichler, H G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

ACE; Glucose; Human skeletal muscle; In vivo microdialysis; Paracrine

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; GLUCOSE; INSULIN; LACTIC ACID;

ADULT; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; MALE; MICRODIALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; VOLUNTEER;

EID: 0030730184     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1920746.x     Document Type: Article

References (26)

1. The Consensus Study Trial Group. Effects of enalaprilate on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-35.
2. Donnelly R. Angiotensin converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes and heart failure. J Cardiovasc Pharmacol 1992;20 (Suppl. 11):S38-44.
3. Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995;44:267-72.
4. Pollare T, Lithell H, Berne C. A comparison of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-73.
5. Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependent diabetes mellitus. Eur J Clin Invest 1987;17:448-54.
6. Torlone E, Britta M, Rambotti AM et al. Improved insulin action and glycaemic control after long-term Angiotensin Converting Enzyme inhibition in subjects with arterial hypertension and Type II diabetes. Diabetes Care 16 1993;10:1347-55.
7. Heinemann L, Heise T, Ampudia J et al. Four week adminstration of an ACE inhibitor and a cardioselective β-blocker in healthy volunteers: no influence on insulin sensitivity. Eur J Clin Invest 1995;25:595-600.
8. Thürig C, Böhlen L, Schneider M et al. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients. Eur J Clin Pharmacol 1995;49:21-6.
9. Ludvik B., Kueenburg L, Brunnbauer M, Schernthaner G, Prager R. The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension. J Cardiovasc Pharmacol 1991;18 (Suppl. 2): S157-9.
10. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
11. Anonymous. ACE inhibitors and tissue binding. Lancet 1990;336: 718-19.
12. Müller M, Schmid R, Georgopoulos A, Buxbaum A, Wasicek C, Eichler HG. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995;57:371-80.
13. Müller M, Schmid R, Nieszpaur-Los M et al. Key metabolite kinetics in human skeletal muscle during ischemia and reperfusion: measurement by microdialysis. Europ J Clin Invest 1995;25:601-7.
14. Müller M, Holmäng A, Anderson O, Eichler HG, Lönnroth P. Measurement of interstitial glucose and lactate concentrations during an oral glucose tolerance test. Am J Physiol 1996 (Endocrinol Metab 34); E1003-7.
15. Jansson PA, Veneman T, Nurjhan N, Gerich J. An improved method to calculate adipose tissue interstitial substrate recovery for microdialysis studies. Life Sci 1994;54:621-4.
16. Galitzky J, Lafontan M, Nordenström J, Arner P, Role of vascular alpha 2 adrenoceptors in regulating lipid mobilization from human adipose tissue, J Clin Invest 1993;91:1997-2003.
17. Reneland R, Lithell H. Angiotensin converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand J Clin Lab Invest 1994;54:105-11.
18. DeFronzo RA. Lilly lecture 1987: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988;37-667-87.
19. Lönnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987 Endocrin Metab 16:E228-31.
20. Fasching P, Ratheiser K, Damjancic P et al. Both acute and chronic near-normoglycaemia are required to improve insulin resistance in Type 1 (insulin dependent) diabetes mellitus. Diabetologia 1993-36-346-51.
21. 113Xe clearance. Clin Sci 1991;86:15-25.
22. Holmäng A, Müller M, Anderson O, Lönnroth P. Microdialysis of muscle interstitial glucose in healthy and type II diabetics(Abstract). Diabetes 1996;45 (Suppl. 2):255a.
23. Maggs DG, Jacob R, Rife F et al. Interstitial fluid concentrations of glycerol, glucose and amino acids in human quadricep muscle and adipose tissue. J Clin Invest 1995;96:370-7.
24. Häring HU, Tippmer S, Kellerer M et al. Modulation of insulin receptor signaling. Potential mechanisms of a cross talk between bradykinin and the insulin receptor. Diabetes 1996;45 (Suppl. 1): S115-S119.
25. Baron AD. The coupling of glucose metabolim and perfusion in human skeletal muscle, the potential role of endothelium derived nitric oxide. Diabetes 1996;45 (Suppl. 1):S105-9.
26. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994;267:E187-202.